• Ashton J.R., Seymour H (2010). Public Health and the origins of the Mersey Model of Harm Reduction. International Journal of Drug Policy 21, 94-96. 
  • Barrett D, et al. (2022). Child-centred harm reduction. International Journal of Drug Policy 109, 103857. 
  • Belackova, V., & Salmon, A. (2017). Overview of international literature - supervised injecting facilities & drug consumption rooms - Issue 1. 
  • British Columbia Centre on Substance Use. (2019). Heroin Compassion Clubs. A cooperative model to reduce opioid overdose deaths & disrupt organized crime’s role in fentanyl, money laundering & housing unaffordability. https://substanceuse.ca/sites/default/files/2021-04/Report-Heroin-Compassion-Clubs.pdf 
  • Davis, P., & Lichtenstein, B. (1996). In P. Davis (Ed.), AIDS, sexuality and the social order in New Zealand. Intimate details and vital statistics. Auckland: Auckland University Press. 
  • Denis-Lalonde D et al. (2019). Beyond the Buzzword: A Concept Analysis of Harm Reduction. Research and Theory for Nursing Practice: An International Journal, 33(4). 
  • Drug Policy Alliance (2015). Drug Decriminalization in Portugal: A Health-Centered Approach. Available from: https://idpc.net/publications/2014/03/drug-decriminalization-in-portugal-a-health-centered-approach  
  • Greer, A. M., Luchenski, S. A., Amlani, A. A., Lacroix, K., Burmeister, C., & Buxton, J. A. (2016). Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada. BMC Public Health, 16(1), 452. https://doi.org/10.1186/s12889-016-3136-4 
  • Harm Reduction International. (2023). What is Harm Reduction? https://hri.global/what-is-harm-reduction/ 
  • Harris, M. (2021). Creativity, care and ‘messy’ drug use: A collective history of the early days of peer-led needle exchange in Dunedin, New Zealand. International Journal of Drug Policy, 98, 103386. 
  • Harris, M. (2013). The ’do-it-yourself’ New Zealand injecting scene: Implications for harm reduction. International Journal of Drug Policy, 24(4), 281–283. https://doi.org/10.1016/j.drugpo.2012.06.007 
  • Hawk, M., Coulter, R. W. S., Egan, J. E., Fisk, S., Reuel Friedman, M., Tula, M., & Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(1), 70. https://doi.org/10.1186/S12954-017-0196-4/TABLES/2 
  • Health Canada. (2021). Early findings from safer supply pilot projects. https://www.canada.ca/content/dam/hc-sc/documents/services/opioids/responding-canada-opioid-crisis/safer-supply/early-findings-safer-supply-pilot-projects/early-findings-safer-supply-pilot-projects.pdf 
  • INPUD Secretariat. (2020). Taking back what’s ours! https://inpud.net/taking-back-whats-ours-a-documented-history-of-the-movement-of-people-who-use-drugs/ 
  • Keen, D., & Weston, E. (2021). New Zealand Needle Exchange Programme. Cost-Benefit Analysis Report. https://www.nznep.org.nz/media/pdfs/411.pdf 
  • Kemp, R., & Aitken, C. (2004). The development of New Zealand’s Needle and Syringe Exchange Programme. The International Journal of Drug Policy, 15, 202-206. 
  • Kimmel S et al. (2021). Principles of harm reduction for young people who use drugs. Pediatrics, 147(2), S240-S248. 
  • Lenton, S., & Single, E. (1998). The definition of harm reduction. Drug and alcohol review, 17(2), 213-219. 
  • Luke, S. M. (2007). Needle Exchange Networks: The emergence of 'peer-professionals'. 
  • Lungley, S., & Baker, M. (1990). The needle and syringe exchange scheme in operation: an evaluation of the first year. Department of Health, Health Research Services. 
  • Maghsoudi, N., Tanguay, J., Scarfone, K., Rammohan, I., Ziegler, C., Werb, D., & Scheim, A. I. (2022). Drug checking services for people who use drugs: a systematic review. Addiction, 117(3), 532–544. https://doi.org/https://doi.org/10.1111/add.15734 
  • Marlatt, G. A. (1998). Harm reduction: Pragmatic strategies for managing high risk behaviors. Guilford Press. 
  • McLachlan, A., Waitoki, W. (in press). Tawhiti: An Indigenous Trauma-Informed Harm Reduction Approach to Alcohol and Other Drug Use. Journal of Indigenous Wellbeing: Te Mauri – Pimatisiwin. 
  • Milaney, K., Haines-Saah, R., Farkas, B., Egunsola, O., Mastikhina, L., Brown, S., Lorenzetti, D., Hansen, B., McBrien, K., Rittenbach, K., Hill, L., O’Gorman, C., Doig, C., Cabaj, J., Stokvis, C., & Clement, F. (2022). A scoping review of opioid harm reduction interventions for equity-deserving populations. The Lancet Regional Health – Americas, 12. https://doi.org/10.1016/j.lana.2022.100271 
  • National Harm Reduction Coalition, Academy of Perinatal Harm Reduction (2020). Pregnancy and substance use: a harm reduction toolkit. https://harmreduction.org/issues/pregnancy-and-substance-use-a-harm-reduction-toolkit/ 
  • National Harm Reduction Coalition. (2020). Principles of Harm Reduction. https://harmreduction.org/wp-content/uploads/2022/12/NHRC-PDF-Principles_Of_Harm_Reduction.pdf 
  • Noller, G. (2007). Cannabis in New Zealand: Use, users and policy. Pp 98-104. Unpublished PhD Thesis. University of Otago. Available at: https://geoffnoller.nfshost.com/wp-content/uploads/2016/05/Geoff_Noller_PhD.pdf  
  • Parliamentary debates (1987). 17 June Misuse of Drugs Amendment Bill, 481, 9607–9614. https://babel.hathitrust.org/cgi/pt?id=uc1.l0107625261&view=page&format=plaintext&seq=305&q1=needle   
  • Pitama S, Huria T, Lacey C (2014). Improving Māori health through clinical assessment: Waikare o te Waka o Meihana. New Zealand Medical Journal 127(1393). 
  • Rasmussen, I. S., Arefjord, K., Winje, D., & Dovran, A. (2018). Childhood maltreatment trauma: A comparison between patients in treatment for substance use disorders and patients in mental health treatment. European Journal of Psychotraumatology, 9(1). https://doi.org/10.1080/20008198.2018.1492835 
  • Rigoni, R., Breeksema, J., & Woods, S. (2018). Speed Limits: Harm reduction for people who use stimulants. http://mainline-eng.blogbird.nl/uploads/mainline-eng/2018_Mainline_%E2%80%93_Harm_Reduction_for_People_Who_Use_Stimulants_%E2%80%93_Full_Report.pdf 
  • Riley, D., & Pates, R. (Eds.). (2012). Harm Reduction in Substance Use and High-Risk Behaviour. John Wiley & Sons. 
  • Ritter, A., & Cameron, J. (2006). A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 611–624. 
  • Single, E., & Lenton, S. (1995). Defining harm reduction. Drug and Alcohol Review, 14(3), 287–290. 
  • Stimson G (2007). "Harm Reduction-Coming of Age": A local movement with global impact. International Journal of Drug Policy, 18(2), 67-69. 
  • Strike C, Watson TM. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Int J Drug Policy. 2019 Sep;71:178-182. doi: 10.1016/j.drugpo.2019.02.005. Epub 2019 Apr 8. PMID: 30975595. 
  • Taha, S. (2018). Best Practices across the Continuum of Care for Treatment of Opioid Use Disorder. 
  • Toumbourou, J., Stockwell, T., Neighbors, C., Marlatt, G., Sturge, J., & Rehm, J. (2007). Interventions to reduce harm associated with adolescent substance use. Lancet, 369(9570), 1391–1401. https://doi.org/10.1016/S0140-6736(07)60369-9 
  • Weatherburn, D. (2009). Dilemmas in harm minimization. Addiction, 104(3), 335–339. 
  • Weber, A., Miskle, B., Lynch, A., Arndt, S., & Acion, L. (2021). Substance Use in Pregnancy: Identifying Stigma and Improving Care. Substance Abuse and Rehabilitation, 12, 105–121. 
  • Wodak, A., Ryan, J., Griffiths, P., Beek, I. V., Barratt, M. J., Lenton, S., ... & Farrell, M. P. (2012). Policy and practice in harm reduction in Australasia. Harm Reduction in Substance Use and High-Risk Behaviour: International Policy and Practice, 415-424. 
  • World Health Organization. (2011). Therapeutic interventions for users of amphetamine-type stimulants (ATS). https://apps.who.int/iris/bitstream/handle/10665/272729/ats-brief-4.pdf?sequence=4&isAllowed=y 

More tools and resources

Ethical harm reduction practice

Ethical considerations for Harm Reduction in health practice

Service reflection tool

Strengthening your service’s ability to create an environment that enables harm reduction.

Talking about reducing risks with substance use

Guidance on how to have conversations with people about reducing potential risks when they use substances.